Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04) October 11, 2017 Kindred Bio To Announce Fourth Quarter And Year-End 2016 Financial Results February 20, 2017 NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017
NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017